Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Low-Energy Fridays: Is lightning-fast permitting possible?
Illinois Needs a Clean Slate—Because We Can’t Define People by Their Worst Days
Real Insights: Finding Meaning in the Microcosm—A Conversation with Jonah Goldberg
The Credit Card Amendments Putting the GENIUS Act at Risk
The federal government should not interfere with local prosecutors